by CCRM Australia | Dec 6, 2022
Bhavi Kadakia was an intern with CCRM Australia in 2020 and is currently employed at Novotech. In the health-care sector, translation and commercialization have traditionally been described as complex and requiring heavy investment. As such, it is imperative for...
by Stacey Johnson | Nov 25, 2022
If manufacturing is the gatekeeper to success in the cell and gene therapy space, it’s not surprising that the topic regularly comes up when industry leaders come together to discuss the future or to tackle the challenges we face in commercializing cell and gene...
by Stacey Johnson | Nov 4, 2022
Despite valiant efforts by countless people and organizations, misinformation and a lack of public trust in science continue to be prevalent themes in 2022. Day two of the Till & McCulloch Meetings in Vancouver kicked off with an informative plenary exploring...
by Kevin Robb | Oct 14, 2022
My heart is pounding, and my islets are secreting. Maybe it’s my fifth cup of sugary coffee kicking in, or maybe they’ve been inspired by the plenary session I’m recalling. While the former is more likely, I toy with the idea of the latter. In the “Clinical...
by Stacey Johnson | Sep 30, 2022
After returning from CellCAN’s 2022 Strategic Forum in Ottawa, Ontario, where Canada’s cell and gene therapy biomanufacturing community came together to share information and network, it is clear that the country’s biomanufacturing landscape is improving. As I and...
Comments